APA (7th ed.) Citation

Sror, N., Leibovitzh, H., Hirsch, A., Thurm, T., Ron, Y., Maharshak, N., & Cohen, N. A. (2025). Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic‐Experienced Patients With Ulcerative Colitis: A Retrospective Study. Journal of Digestive Diseases, 26(9/10), 428. https://doi.org/10.1111/1751-2980.70012

Chicago Style (17th ed.) Citation

Sror, Neta, Haim Leibovitzh, Ayal Hirsch, Tamar Thurm, Yulia Ron, Nitsan Maharshak, and Nathaniel Aviv Cohen. "Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic‐Experienced Patients With Ulcerative Colitis: A Retrospective Study." Journal of Digestive Diseases 26, no. 9/10 (2025): 428. https://doi.org/10.1111/1751-2980.70012.

MLA (9th ed.) Citation

Sror, Neta, et al. "Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic‐Experienced Patients With Ulcerative Colitis: A Retrospective Study." Journal of Digestive Diseases, vol. 26, no. 9/10, 2025, p. 428, https://doi.org/10.1111/1751-2980.70012.